1.
Ann Hepatol
; 7(1): 46-51, 2008.
Artículo
en Inglés
| MEDLINE
| ID: mdl-18376365
RESUMEN
Hepatocellular carcinoma is a lethal disease that requires a multidisciplinary approach and management. Surgical therapy offers long-term survival; however, few patients are candidates. There has been no accepted systemic therapy for this disease until recently. This article briefly discusses the role of RAS/RAF/MEK/ERK signaling pathway in the pathogenesis of the disease and the promising role of sorafenib for advanced disease.